Sako K, Nakamaru Y, Ikawa K, Maeda T, Goto S, Ishihara Y, Kato Y, Matsuda Y. Population Pharmacokinetics and dosing optimization of teicoplanin in neutropenic patients with hematological malignancies. Ther Drug Monit 43(4): 519-526, 2021. ※日本薬科大学グループが中心の共同研究